BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 2864160)

  • 41. Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels.
    Palma JA; Fernandez-Torron R; Gallego Perez-Larraya J
    Clin Neuropharmacol; 2010; 33(2):102-3. PubMed ID: 20375657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy of affective disorders.
    Alexander B; Cook B
    Prim Care; 1990 Sep; 17(3):565-88. PubMed ID: 2236337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schizophrenia and bipolar affective disorders: likenesses and differences.
    Klein DF
    Hillside J Clin Psychiatry; 1989; 11(1):3-15. PubMed ID: 2613186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report].
    Hydzik P; Balicka-Slusarczyk B; Jastrzebski M
    Przegl Lek; 2011; 68(8):499-502. PubMed ID: 22010449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbamazepine in the prophylaxis of mood disorders.
    Stuppaeck C; Barnas C; Miller C; Schwitzer J; Fleischhacker WW
    J Clin Psychopharmacol; 1990 Feb; 10(1):39-42. PubMed ID: 2307735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment.
    Arana GW; Santos AB; Knax EP; Ballenger JC
    J Clin Psychiatry; 1989 Sep; 50(9):356-7. PubMed ID: 2768205
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbamazepine in manic-depressive illness: a new treatment.
    Ballenger JC; Post RM
    Am J Psychiatry; 1980 Jul; 137(7):782-90. PubMed ID: 7386656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
    Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
    Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of carbamazepine in polyuria associated with lithium therapy.
    Ghose K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):241-5. PubMed ID: 360249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addition of lithium carbonate to carbamazepine: hematological and thyroid effects.
    Kramlinger KG; Post RM
    Am J Psychiatry; 1990 May; 147(5):615-20. PubMed ID: 2109539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of electroconvulsive therapy for breaking the continual course of drug-resistant affective and schizoaffective psychoses].
    Mosolov SN; Moshchevitin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):121-5. PubMed ID: 2167575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Eight years follow-up of lithium prophylaxis in patients of psychiatric-neurological practice (author's transl)].
    Kurek M; Consbruch U
    Pharmacopsychiatria; 1982 Mar; 15(2):65-9. PubMed ID: 7079292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lithium carbonate in the treatment of schizophrenia and schizo-affective disorder: review and hypothesis.
    Miller FT; Libman H
    Biol Psychiatry; 1979 Aug; 14(4):705-10. PubMed ID: 486621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
    Keisling R
    Arch Gen Psychiatry; 1983 Feb; 40(2):223. PubMed ID: 6401989
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
    Post RM
    Psychol Med; 1982 Nov; 12(4):701-4. PubMed ID: 6130553
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report.
    Kwamie Y; Persad E; Stancer H
    Can J Psychiatry; 1984 Nov; 29(7):605-8. PubMed ID: 6150757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term therapy of affective disorders: monotherapy or polypharmacy?
    König W; Rissom R; Kalfoglu G; Stein A; Reimer F
    Pharmacopsychiatry; 1988 Nov; 21(6):272-3. PubMed ID: 3244749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.